Monday, May 3, 2010 - Wednesday, May 5, 2010
ENGLISH
Third-Party Event
Organization Name: BIO (Biotechnology Industry Organization)

The 2010 BIO International Convention, presented by the Biotechnology Industry Organization (BIO), returns to Chicago’s McCormick Place May 3-6 and once again the  Japan External Trade Organization (JETRO) is the official organizer of the Japan Pavilion.  With the world's second largest economy and the second largest biotech market, Japan is a key player in life science sector.  For the BIO Chicago, 18 organizations will travel from Japan to exhibit in the Japan Pavilion.  Many of these exhibitors are pioneers in biopharmaceuticals, diagnostics, and regenerative medicine. These firms will present their leading-edge technologies, products and services on this key global stage. 

JETRO will also present an international case study on Tuesday, May 4 at 9:00 AM.  “From Regional to Global – Open Innovation Giving Boost to Japanese Bio SMEs” will explore how the government has helped create more than 700 new biotech companies and the impact their research and technology is having.

If you or your colleagues are interested in touring the Japan Pavilion with a guide from JETRO, please contact Robert Corder at 773-545-3817 or robert_corder@jetro.go.jp. We look forward to seeing you in Chicago.

BIO 2010 JAPAN PAVILION EXHIBITORS

CellSeed Inc.

CellSeed is a biotechnology innovator focused on novel surface and cell culture products. CellSeed is dedicated to providing innovative solutions for tissue-engineering through development of novel cell harvest methods and 3-dimensional living tissue replacement products for "cell-sheet therapy" and regenerative medicine.  CellSeed is committed to providing solutions for patients suffering from certain incurable diseases. At BIO 2010, CellSeed will exhibit products for regenerative medicine (e.g. autologous regenerative medicine using "cell-sheet engineering").

http://www.cellseed.com/company-e/index.html

DNAVEC Corporation

DNAVEC’s business activities include: licensing of drug candidates to domestic and overseas partners; developing drug development pipelines through DNAVEC’s own research programs and collaboration with others; building multifaceted bio-business on the platform technology of novel vectors; development of high-performance vectors; searching for transgenes suitable for the business objectives; and consultation on technology and business, especially in China.  At BIO 2010, DNAVEC will be exhibiting new developments in “PlasmaEX,” a high-performance system for cytoplasmic expression; gene therapy for critical limb ischemia using PlasmaEX; gene vaccines (AIDS, Alzheimer’s disease); and therapeutic antibodies, regenerative medicine & cell therapy (preparation of iPS cells, cancer immunotherapy using activated dendritic cells)

http://www.dnavec.co.jp/en/index.html

DS Pharma Biomedical Company, Ltd.

DS Pharma is engaged in research, development and supply of point-of-care tests (POCT) to detect influenza and acute myocardial infarction. DS Pharma also manufactures analytical kits for measuring bone & calcium metabolic markers. DS Pharma supplies cell lines, culture media, sera, reagents and devices to research organization and universities. 

http://www.dspbio.co.jp/english/profile.html

GenoMembrane, Inc.

GenoMembrane, Inc. was established as a bio-tech venture company in 2002 to provide transporter-related products and services that will be useful in the development and design of novel drugs for clinical application. GenoMembrane also provides research services or collaboration in the pharmacological evaluation of drug candidates to minimize costs, help improve the success rate of candidate drugs, and speed up new drug development. GenoMembrane has developed a convenient in vitro assay system to assess the affinity of various drug transporters with drug candidates.

http://www.genomembrane.com/English

Hashimoto Electronic Industry Company, Ltd.

Liposome Engineering Laboratory Inc.

The Hashimoto Electronic Industry Company designs and manufactures advanced electronics used in the biotech and life science sectors.  This includes precision equipment for measurement & analysis and a fully automatic multi-functional system for liposome production.  The unique, easy-to-operate device allows even unskilled users to prepare desired types of liposomes overnight with a single touch of a button.

http://www.hashimoto-inc.co.jp/index.html

http://www.lel.co.jp

Hokkaido University Center for Innovation and Business Promotion

The Hokkaido University Center for Innovation and Business Promotion was created in 2009 to promote the creation, protection and effective utilization of intellectual properties created by university researchers in a proactive and systematic manner.  The Center seeks to aid in the revitalization of the local economy and help enhance the nation’s international competitiveness by promoting educational and enlightenment activities relating to intellectual property and returning HU’s intellectual properties to society. In addition to creating new intellectual properties and promoting industry-university collaboration, the Center works to promote innovation and create venture businesses and new industries with intellectual property as the core of industry-academia-government collaborations.

http://www.mcip.hokudai.ac.jp/eng/

Japan Bioinformatics KK

Japan Bioinformatics KK specializes in providing data and information management, computational and consulting services to life sciences industries, including pharmaceutical, diagnostics, biotechnology, research and healthcare. At BIO2010, we will demonstrate Simbiot, a next generation system for managing biological data, giving an easy-to-use interface to the most modern algorithms and analysis tools. The main features include data management, data analysis, collaborative research, data distribution and MIAME compliance.

http://www.japanbioinformatics.com/

Japan Biological Informatics Consortium (JBIC)

The JBIC is a non-profit organization under the auspices of four Japanese government ministries and agencies. JBIC’s mission is to facilitate research and development in the biotechnology industry by applying information technology and to create new biotechnology industries through projects and activities based on mutual exchanges of information among member companies

http://www.jbic.or.jp/bio/english/

Kanazawa University Technology Licensing Organization (KUTLO)

KUTLO promotes licensing and technology transfer for twelve research organizations located on Japan’s northwestern sea coast.  These organizations include Hirosaki University, Yamagata University, Niigata University, Niigata Univ. of Pharmacy & ALS, University of Toyama, Kanazawa Medical University, Kanazawa University, Ishikawa Pref. University, University of Fukui, Doshisha University, Niigata TLO, and Kanazawa University TLO.

http://kutlo.incu.kanazawa-u.ac.jp/

Kansai Technology Licensing Organization Co., Ltd.

We provide necessary management support for intellectual property rights held by Kyoto University, Kyoto Prefectural University of Medicine, Ritsumeikan University, Wakayama University and others, and also facilitate the transfer of useful rights to the industrial sector. At BIO 2010, Kansai TLO will exhibit advancements in recombinant DNA techniques and gene carrier technology.

http://www.kansai-tlo.co.jp/english/index.php

NANOEGG Research Laboratories, Inc.

NANOEGG has developed a unique drug-encapsulating technology, which has high potential of skin care effects such as whitening and anti-aging.  NANOEGG has also developed NANOCUBE, transparent gel that can accelerate the permeation of active ingredients into skin without any physical and chemical damage. MOISTURECUBE, a product derived from the NANOCUBE technology, has significant moisturizing properties and can regenerate epidermal layers, transport various active ingredients via skin barrier, and improve pigmentation and wrinkles. The company is actively looking for partners interested in the following fields: overseas development partner for nano-encapsulated retinoic acid using NANOEGG technology; development partners for NANOCUBE gel with applications such as cosmetics, pharmaceuticals, food & beverages, and other chemical uses; promotion partners for our MARIANNA cosmetics line.

http://www.nanoegg.co.jp/en/index.html

Osaka Bio Headquarters (Osaka Prefectural Government)

Osaka Bio Headquarters helps local bio ventures to expand their presence around the world.  The organization also promotes international exchange activities with overseas biomedical clusters in the hope that such events provide foreign companies with opportunities to establish their businesses in Osaka.  Osaka Bio Headquarters will attend BIO 2010 to represent companies in the Osaka Bio Cluster, including AnGes MG, Kringle Pharma and GeneDesign.

http://www.osaka-bio.jp/en/

PropGene, Inc.

PropGene develops test reagents and analytical systems. The company also manufactures, markets and consults for biomedical technologies. At BIO 2010, PropGene will exhibit a detection system with a microarray for acid fast bacteria and a diagnostic test kit for disease susceptibility, such as metabolic syndrome.

http://www.pgi.jp/english/top/index.html

ReqMed Company Ltd.

ReqMed serves as a bridge between Japanese biotech ventures and pharmaceutical firms. Operations are focused on pharmaceutical development through early establishment of “proof of concept” and increasing added-value with alliances, business development consulting, and investments in biotech ventures. ReqMed currently supports the development of drugs for osteoarthritis (Sodium Pentosan Polysulfate [NaPPS] – currently in preparation for Phase 2 trials in Japan) and ADHD/ADD (eltoprazine - Phase 2 trials completed in the USA). 

http://www.reqmed.co.jp/mercury/index.cgi?d=index_e&l=e

Todai TLO, Ltd.

Todai TLO manages and markets all of the intellectual property created at the University of Tokyo (UT). More than 600 new inventions are created by UT researchers annually.  By transferring the knowledge created at UT to society at large, our aim is to help create an environment in which people all over the world can world can live in health and safety.  At BIO 2010, Todai TLO will exhibit advances in drug & diagnostics discovery as well as new research tools and medical devices.

http://www.casti.co.jp/english/index.html

Tohoku Techno Arch Company, Ltd.

Tohoku Techno Arch Co., Ltd. (TTA) is a technology licensing organization and promotes the transfer of technologies invented from researchers in Tohoku University, Japan. TTA provides medical, pharmacological and biochemical inventions and contributes to make opportunities for technology transfer and collaboration between Tohoku University and foreign companies.

http://www.t-technoarch.co.jp/en/index.html

Tokyo Future Style, Inc.

Tokyo Future Style serves as the global marketer & sales representative for several Japan bio-ventures.   In 2009, the company started Tokyo-BioVentures, an online initiative to help their clients’ technology find new research and business development collaborators.

http://www.tokyofuturestyle.com/english

Location: